EASL Clinical Practice Guidelines: Management of hepatitis C virus infection Journal of Hepatology , Volume 60 , Issue 2 , 392 - 420 http://www.journal-of-hepatology.eu/article/S0168-8278(13)00794-0/fulltext

https://www.ncbi.nlm.nih.gov/pubmed/27553377Grebely J et al.: Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients with Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials. Clin Infect…

HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina. Skocibusic S, Martinac M, Arapovic J, Grgic S, Nikolic J, Hasanagic D, Bevanda M, Ravlija J. J Infect Dev Ctries. 2016 Sep 3…

11.11.2016 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004169/smops/Positive/human_smop_001061.jsp&mid=WC0b01ac058001d127

Gilead, press release, 10.10.2016 http://www.gilead.com/news/press-releases/2016/11/us-food-and-drug-administration-approves-gileads-vemlidy-tenofovir-alafenamide-for-the-treatment-of-chronic-hepatitis-b-virus-infection 

(aerzteblatt.de, 01.11.2016) http://www.aerzteblatt.de/nachrichten/71097